文献速递内脏/肾动脉与血管畸形

多囊肾动脉栓塞用于异位肾移植前减容

Arterial Embolization of Polycystic Kidneys for Heterotopic Transplantation.
PubMed 文献 · J Endovasc Ther · 2022-01-11

研究纳入2014年6月至2020年2月前瞻性登记的29例透析患者共31次移植前多囊肾动脉栓塞,技术成功率96.8%,平均肾脏体积缩小39.9%,28例(96.5%)体积缩小足以接受移植,主要并发症为栓塞后疼痛10例(32.2%),23例(79.3%)随访期间接受肾移植。

要点

  • 移植前多囊肾动脉栓塞技术成功率96.8%,平均体积缩小39.9%。
  • 96.5%患者体积缩小足以接受异位肾移植,79.3%随访期间完成移植。
  • 主要并发症为栓塞后疼痛,发生于32.2%的病例。

核心结论

  • 多囊肾动脉栓塞是一种有效且安全的微创技术,可作为移植前肾切除术的替代方案,作者提出其可作为肾移植受者的首选技术。

研究设计与样本

  • 前瞻性登记研究,纳入2014年6月至2020年2月所有接受移植前多囊肾动脉栓塞的患者,共29例患者31次栓塞,平均年龄55.6岁,62.1%为男性,栓塞前均接受透析(腹膜透析9例,血液透析20例)。
  • 栓塞前均行CT扫描及体积重建(OsiriX,Bernex,瑞士),栓塞后3个月和6个月随访。
  • 主要结局为肾脏体积缩小百分比,次要结局为30天死亡率和并发症。

主要发现

  • 技术成功率为96.8%,平均手术时间65分钟(范围35-106分钟),平均住院时间3.8天(范围3-6天)。
  • 28例患者(96.5%)获得足以接受肾移植的体积缩小,平均体积缩小39.9%(范围6.01-68.2)。
  • 主要并发症为栓塞后疼痛10例(32.2%),1例因体积缩小不足需补充肾切除术。
  • 23例患者(79.3%)随访期间接受肾移植,平均延迟19.5个月(范围4-54个月)。

临床怎么用

  • 作者认为多囊肾动脉栓塞可作为肾移植受者移植前肾切除术的替代方案,并可提出作为首选技术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The purpose of this study was to evaluate the efficacy of polycystic kidney embolization, performed to reduce kidney volume before heterotopic kidney transplantation, as this technique could be an alternative to pretransplant nephrectomy. MATERIALS AND METHODS: All patients who underwent pretransplant embolization of polycystic kidneys were included in a prospective register from June 2014 to February 2020. All patients underwent computed tomography (CT) scan with volumetric reconstruction (OsiriX, Bernex, Switzerland) before embolization and were then followed up at 3 and 6 months after embolization. Primary outcome was percentage of kidney volume reduction. Secondary outcomes were 30 day mortality and morbidity. RESULTS: Thirty-one embolizations performed on 29 patients (medium age = 55.6; 62.1% male) were included between June 2014 and February 2020. All patients were under dialysis before embolization (9 peritoneal dialysis and 20 hemodialysis). Technical success was observed in 96.8% of cases. Mean procedural time was 65 minutes (range = 35-106 minutes) and mean length of in-hospital stay was 3.8 days (range = 3-6 days). A volume reduction allowing a kidney transplant was obtained for 28 patients (96.5%). The mean volume reduction was 39.9% (range = 6.01-68.2). The main observed complication was postembolization pain in 10 cases (32.2%). One patient needed complementary nephrectomy due to insufficient volume reduction. Twenty-three patients (79.3%) received renal transplant during follow-up with a mean delay of 19.5 month (range = 4-54). CONCLUSION: Polycystic kidney embolization is an effective and safe minimally invasive technique. It can be proposed as the first-choice technique for kidney transplant recipients as an alternative to pretransplantation nephrectomy.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Del Tatto B, Gogeneata I, Ohana M, et al. Arterial Embolization of Polycystic Kidneys for Heterotopic Transplantation. J Endovasc Ther. 2022. PMID: 35012405. doi:10.1177/15266028211067727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。